Virginia Business Bulletin: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Virginia Business Bulletin.

Press releases published on October 24, 2026

4 hours ago

Thousands of Ontarians to Attend ‘Together for Publicly Funded Education’ Rallies

Indeterminate GlobeNewswire

4 hours ago

2026 National Poppy Campaign launches with a donation “first” … and stunning mural: Don’t forget to Remember

Indeterminate GlobeNewswire

4 hours ago

JelluTide Gummies Introduces Jellu Tide Multi-Ingredient Dietary Supplement Formulation

Indeterminate GlobeNewswire

5 hours ago

JST Buyback & Burn Upgrade: GasFree Revenue and $20.34M Surplus Injected as JUST's Ecosystem Trio Solidifies JST Token Value

Indeterminate GlobeNewswire

5 hours ago

XBiotech gibt die Wahl von Sushma Shivaswamy und Jan-Paul Simard zu Co-Chief Executive Officers bekannt

Indeterminate GlobeNewswire

5 hours ago

XBiotech annonce la nomination de Sushma Shivaswamy et Jan-Paul Simard aux postes de co-directeurs généraux

Indeterminate GlobeNewswire

6 hours ago

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Bank of America Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BAC

Indeterminate GlobeNewswire

6 hours ago

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Lincoln Educational Services Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - LINC

Indeterminate GlobeNewswire

6 hours ago

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Qfin Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QFIN

Indeterminate GlobeNewswire

6 hours ago

NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma

Indeterminate GlobeNewswire

6 hours ago

NANOBIOTIX annonce les résultats complets de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle immunitaires chez des patients atteints de mélanome cutané résistant aux anti-PD-1, en traitement de de…

Indeterminate GlobeNewswire

6 hours ago

ROSEN, THE FIRST FILING FIRM, Encourages Netcapital Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NCPL

Indeterminate GlobeNewswire

6 hours ago

Asyad Group to Host Muscat Maritime Resilience Forum to Strengthen Global Trade Networks

Indeterminate GlobeNewswire

7 hours ago

ROSEN, THE FIRST FILING FIRM, Encourages Webull Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BULL

Indeterminate GlobeNewswire

9 hours ago

Alkanes borrningar bekräftar och utvidgar guld-antimon-mineralsystemet vid Nagambie i Victoria

Indeterminate GlobeNewswire

9 hours ago

Tecnover Celebrates 41 Years of Italian Airless Spray-Painting Innovation

Indeterminate GlobeNewswire

10 hours ago

INTELLIGENCE, ENLIGHTENED: LUXEED Makes Its Global Debut, Redefining Luxury and Driving Pleasure Through Intelligence

Indeterminate GlobeNewswire

11 hours ago

Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence

Indeterminate GlobeNewswire

11 hours ago

Darolutamidi yhdessä ADT- ja sädehoidon kanssa vähensi 58 prosentilla syövän leviämisen tai kuoleman vaaraa potilailla, joilla on suuri eturauhassyövän uusiutumisen riski

Indeterminate GlobeNewswire

11 hours ago

Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting

Indeterminate GlobeNewswire